Advanced antisense therapies for postexposure protection against lethal filovirus infections (Nature Medicine, abstract, edited)
[Source: Nature Medicine, summary: <cite cite="http://www.nature.com/nm/journal/v16/n...
9 results in 0.0438 seconds.
-
Giuseppe started a topic Nature. Advanced antisense therapies for postexposure protection against lethal filovirus infectionsin EbolaNature. Advanced antisense therapies for postexposure protection against lethal filovirus infections
-
BMJ. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis
Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis -- Jefferson et al. 339: b5106 (BMJ, abstract, edited)
Published 8 December 2009, doi:10.1136/bmj.b5106...
Cite this as: -
N Engl J Med. Emergence of Oseltamivir-Resistant Pandemic H1N1 Virus during Prophylaxis
Emergence of Oseltamivir-Resistant Pandemic H1N1 Virus during Prophylaxis (N Engl J Med., edited)
Emergence of Oseltamivir-Resistant Pandemic H1N1 Virus during Prophylaxis
<!-- PLUGH $RESOURCE.EXT_DOI is 10.1056/NEJMc0910060... -
J Infect Dis. Pre- and Postexposure Use of Human Monoclonal Antibody against H5N1 and H1N1 Influenza Virus in Mice: Viable Alternative to Oseltamivir.
J Infect Dis. 2009 Dec 15;200(12):1870-1873.
Pre- and Postexposure Use of Human Monoclonal Antibody against H5N1 and H1N1 Influenza Virus in Mice: Viable Alternative to Oseltamivir.
Koudstaal W, Koldijk MH, Brakenhoff JP, Cornelissen... -
N Engl J Med. Emergence of Oseltamivir-Resistant Pandemic H1N1 Virus during Prophylaxis
Emergence of Oseltamivir-Resistant Pandemic H1N1 Virus during Prophylaxis (NEJM, extract, edited)
Emergence of Oseltamivir-Resistant Pandemic H1N1 Virus during Prophylaxis...
To the Editor:
Neuraminidase inhibitors -
Euro Surveill. Measures against transmission of pandemic H1N1 influenza in Japan in 2009: simulation model
Measures against transmission of pandemic H1N1 influenza in Japan in 2009: simulation model (Euro Surveill., edited)
Eurosurveillance, Volume 14, Issue 44, 05 November 2009...
Rapid communications
Measures against transmission -
WER. Oseltamivir-resistant pandemic (H1N1) 2009 influenza virus, October 2009
Oseltamivir-resistant pandemic (H1N1) 2009 influenza virus, October 2009 (Weekly Epidemiological Record, edited)
[Original Full PDF Document: LINK. EDITED.]
Weekly epidemiological record - 30 october 2009, 84th year -... -
Am J Prev Med. Oseltamivir for Influenza Postexposure Prophylaxis: Economic Evaluation for Children Aged 1?12 Years in the U.S.
Oseltamivir for Influenza Postexposure Prophylaxis: Economic Evaluation for Children Aged 1?12 Years in the U.S. (abstract, edited)
Oseltamivir for Influenza Postexposure Prophylaxis: Economic Evaluation for Children Aged 1?12 Years in the U... -
WHO - Antiviral use and the risk of drug resistance (9/25/09)
WHO - Antiviral use and the risk of drug resistance (9/25/09)
Antiviral use and the risk of drug resistance...
Pandemic (H1N1) 2009 briefing note 12
25 SEPTEMBER 2009 | GENEVA
Growing international